Vital Therapies Inc. | Mutual Funds
Mutual Funds that own Vital Therapies Inc.
1,730,793
4.09%
109,370
0.64%
06/30/2018
Vanguard Total Stock Market Index Fund
719,333
1.7%
23,800
0%
07/31/2018
iShares Russell 2000 ETF
636,335
1.5%
-339
0.01%
09/06/2018
JNL/Eagle Small Cap Equity Series
523,465
1.24%
-109,570
0.2%
03/31/2018
Fidelity Select Biotechnology Portfolio
495,291
1.17%
-108,400
0.04%
07/31/2018
iShares Nasdaq Biotechnology ETF
490,033
1.15%
-6,405
0.04%
09/06/2018
Vanguard Extended Market Index Fund
448,031
1.06%
0
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
300,259
0.71%
0
0.02%
09/06/2018
249,560
0.59%
0
0.77%
06/30/2018
AST Small Cap Growth Opportunities Portfolio
213,711
0.5%
-17,610
0.18%
03/29/2018
| Address |
15010 Avenue of Science
San Diego California 92128
United States
|
|
Employees
|
- |
| Website |
http://www.vitaltherapies.com |
| Updated |
09/14/2018 |
| Vital Therapies, Inc. operates as a biotherapeutic company, which develops a human hepatic cell-based system for the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. |
